The Discounted Cash Flow (DCF) valuation of Aerie Pharmaceuticals Inc (AERI) is (64.14) USD. With the latest stock price at 15.25 USD, the upside of Aerie Pharmaceuticals Inc based on DCF is -520.6%.
Based on the latest price of 15.25 USD and our DCF valuation, Aerie Pharmaceuticals Inc (AERI) is a sell. selling Aerie stocks now will result in a potential gain of 520.6%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.3% - 7.7% | 7.0% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (137.85) - (44.27) | (64.14) |
| Upside | -1003.9% - -390.3% | -520.6% |